Literature DB >> 16896312

MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis.

Reiner Ulrich1, Wolfgang Baumgärtner, Ingo Gerhauser, Frank Seeliger, Verena Haist, Ulrich Deschl, Susanne Alldinger.   

Abstract

Theiler murine encephalomyelitis (TME) represents a highly relevant viral model for multiple sclerosis. Matrix metalloproteinases (MMPs) degrade extracellular matrix molecules and are involved in demyelination processes. To elucidate their impact on demyelination in TME, spinal cords of TME virus (TMEV)-infected SJL/J mice were taken at 9 different time points postinfection (pi) ranging from 1 hour to 196 days pi and investigated for the expression of TMEV, MMP-2, -3, -7, -9, -10, -11, -12, -13, -14, -15, -24, and TIMP-1 to -4 by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). High TMEV RNA levels were detectable throughout the observation period using RT-qPCR. In addition, TMEV RNA was visualized within demyelinated lesions by in situ hybridization. MMP-3 mRNA was significantly upregulated at 1 day pi and again in the late phase of infection. TIMP-1 mRNA was significantly elevated throughout the observation period. MMP-12 mRNA was most prominently upregulated in the late phase of infection and MMP-12 protein was localized in intralesional microglia/macrophages and astrocytes by immunohistochemistry. In summary, in early TMEV infection, MMP-3 and TIMP-1 mRNA upregulation might be directly virus-induced, whereas persistent TMEV infection directly or indirectly stimulated MMP-12 production in microglia/macrophages and astrocytes and might account for ongoing demyelination in TME.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896312     DOI: 10.1097/01.jnen.0000229990.32795.0d

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  30 in total

1.  Inflammation in neuroviral diseases.

Authors:  Pascale Giraudon; Arlette Bernard
Journal:  J Neural Transm (Vienna)       Date:  2010-08       Impact factor: 3.575

Review 2.  Astrocyte, the star avatar: redefined.

Authors:  Pankaj Seth; Nitin Koul
Journal:  J Biosci       Date:  2008-09       Impact factor: 1.826

Review 3.  MMP-12, a Promising Therapeutic Target for Neurological Diseases.

Authors:  Bharath Chelluboina; Koteswara Rao Nalamolu; Jeffrey D Klopfenstein; David M Pinson; David Z Wang; Raghu Vemuganti; Krishna Kumar Veeravalli
Journal:  Mol Neurobiol       Date:  2017-02-02       Impact factor: 5.590

4.  Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination.

Authors:  Evelien Houben; Kris Janssens; Doryssa Hermans; Jennifer Vandooren; Chris Van den Haute; Melissa Schepers; Tim Vanmierlo; Ivo Lambrichts; Jack van Horssen; Veerle Baekelandt; Ghislain Opdenakker; Wia Baron; Bieke Broux; Helena Slaets; Niels Hellings
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

Review 5.  Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke.

Authors:  Kanako Itoh; Takakuni Maki; Josephine Lok; Ken Arai
Journal:  Brain Res       Date:  2015-05-08       Impact factor: 3.252

6.  Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration.

Authors:  Guanghong Liao; Zhuangjun Wang; Erik Lee; Stephanie Moreno; Omar Abuelnasr; Michel Baudry; Xiaoning Bi
Journal:  Exp Neurol       Date:  2015-04-09       Impact factor: 5.330

Review 7.  Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

Authors:  Isis M Ornelas; Lauren E McLane; Aminat Saliu; Angelina V Evangelou; Luipa Khandker; Teresa L Wood
Journal:  J Neurosci Res       Date:  2016-08-25       Impact factor: 4.164

8.  MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology.

Authors:  Kumiko Ijichi; Graham D Brown; Craig S Moore; Jean-Pyo Lee; Paige N Winokur; Roberto Pagarigan; Evan Y Snyder; Ernesto R Bongarzone; Stephen J Crocker
Journal:  Glia       Date:  2013-02-13       Impact factor: 7.452

Review 9.  Looking Inside the Matrix: Perineuronal Nets in Plasticity, Maladaptive Plasticity and Neurological Disorders.

Authors:  Ciro De Luca; Michele Papa
Journal:  Neurochem Res       Date:  2016-03-02       Impact factor: 3.996

10.  Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis.

Authors:  Isobel A Scarisbrick; Hyesook Yoon; Michael Panos; Nadya Larson; Sachiko I Blaber; Michael Blaber; Moses Rodriguez
Journal:  Brain Pathol       Date:  2012-03-21       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.